Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Funding to fuel company's progress as it drives lead AMD program into the clinic and continues development progress across extensive ophthalmology pipeline
SOUTH SAN FRANCISCO, Calif., Jan. 5, 2023 -- (Healthcare Sales & Marketing Network) -- Perceive ... Biopharmaceuticals, Ophthalmology, Venture Capital Perceive Biotherapeutics, retinal blindness
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Blindness | Funding | Marketing | Opthalmology | Pharmaceuticals | Venture Capital | Vitamin A